Biostage Inc, also known as HRGN, is a clinical-stage biotechnology company specializing in regenerative medicine. They have developed a revolutionary technology that uses the patient's own stem cells to regenerate the esophagus after it has been removed due to cancer, trauma, or birth defects. The process involves growing the patient's stem cells on a porous plastic tubular scaffold, which stimulates the body's natural regeneration process.

This scaffold guides the newly-formed tissue to take the shape of the patient's own esophagus. The remarkable aspect is that once the regeneration is complete, the scaffold is removed through the mouth without the need for any surgical incisions or stitches. The HRGN Esophageal Implant is not a transplant of someone else's organ, a pig's organ, or a piece of plastic mesh.

It is the patient's own organ, fully regenerated. Renowned doctors have acclaimed it as a breakthrough treatment with significant clinical applications. The first successful regeneration of an esophagus in a human cancer patient was performed using this implant at Mayo Clinic.

Based on this success, the FDA has approved a clinical trial for the HRGN Esophageal Implant. If you are interested in learning more about this trial, you can contact their Chief Scientific Officer, Dr. William Fodor.

With their groundbreaking technology and dedication to regenerative medicine, Biostage Inc is transforming the field of esophageal regeneration